Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) EBT (2016 - 2023)

Historic EBT for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to -$22.0 million.

  • Mesoblast's EBT fell 210.16% to -$22.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was -$82.1 million, marking a year-over-year increase of 1035.64%. This contributed to the annual value of -$101.8 million for FY2025, which is 1550.25% down from last year.
  • Per Mesoblast's latest filing, its EBT stood at -$22.0 million for Q2 2023, which was down 210.16% from -$18.6 million recorded in Q1 2023.
  • Mesoblast's 5-year EBT high stood at -$7.4 million for Q3 2019, and its period low was -$35.9 million during Q2 2020.
  • Moreover, its 5-year median value for EBT was -$23.3 million (2019), whereas its average is -$22.9 million.
  • Its EBT has fluctuated over the past 5 years, first skyrocketed by 6330.35% in 2019, then plummeted by 24080.37% in 2020.
  • Mesoblast's EBT (Quarter) stood at -$26.9 million in 2019, then grew by 4.6% to -$25.6 million in 2020, then fell by 1.59% to -$26.0 million in 2021, then rose by 5.64% to -$24.6 million in 2022, then rose by 10.58% to -$22.0 million in 2023.
  • Its EBT stands at -$22.0 million for Q2 2023, versus -$18.6 million for Q1 2023 and -$24.6 million for Q4 2022.